CardioRenal is a company dedicated to improving treatment at home for severe heart failure patients. It develops a telemedicine device that allows for the daily measurement of three cardiac biomarkers in a droplet of blood drawn by the patient. CardioRenal's device readings are taken via a point-of-care minilab and installed in the patient’s home.